These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31233131)

  • 1. Rifampin-resistant Tuberculosis in the United States, 1998-2014.
    Sharling L; Marks SM; Goodman M; Chorba T; Mase S
    Clin Infect Dis; 2020 Apr; 70(8):1596-1605. PubMed ID: 31233131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study.
    Prach LM; Pascopella L; Barry PM; Flood J; Porco TC; Hopewell PC; Metcalfe JZ
    AIDS; 2013 Oct; 27(16):2615-22. PubMed ID: 23842135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa.
    Salaam-Dreyer Z; Streicher EM; Sirgel FA; Menardo F; Borrell S; Reinhard M; Doetsch A; Cudahy PGT; Mohr-Holland E; Daniels J; Dippenaar A; Nicol MP; Gagneux S; Warren RM; Cox H
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0036421. PubMed ID: 34460307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
    Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
    AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Oct; 131():43-48. PubMed ID: 28947041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.
    Coovadia YM; Mahomed S; Pillay M; Werner L; Mlisana K
    PLoS One; 2013; 8(11):e77712. PubMed ID: 24223122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in drug-resistant tuberculosis in the United States, 1993-1996.
    Moore M; Onorato IM; McCray E; Castro KG
    JAMA; 1997 Sep; 278(10):833-7. PubMed ID: 9293991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
    Liu Z; Shilkret KL; Finelli L
    Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
    Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
    Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa.
    Mukinda FK; Theron D; van der Spuy GD; Jacobson KR; Roscher M; Streicher EM; Musekiwa A; Coetzee GJ; Victor TC; Marais BJ; Nachega JB; Warren RM; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):196-202. PubMed ID: 22236920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoniazid-monoresistant tuberculosis in the United States, 1993 to 2003.
    Hoopes AJ; Kammerer JS; Harrington TA; Ijaz K; Armstrong LR
    Arch Intern Med; 2008 Oct; 168(18):1984-92. PubMed ID: 18852399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide survey of drug-resistant tuberculosis in the United States.
    Bloch AB; Cauthen GM; Onorato IM; Dansbury KG; Kelly GD; Driver CR; Snider DE
    JAMA; 1994 Mar; 271(9):665-71. PubMed ID: 8080502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
    Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
    BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for and Trends in Isoniazid Monoresistance at Diagnosis of Tuberculosis-United States, 1993-2016.
    Iqbal SA; Armstrong LR; Kammerer JS; Truman BI
    J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):E162-E172. PubMed ID: 31688735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
    E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
    Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020.
    Song WM; Li SJ; Liu JY; Fu Q; Xu TT; Tao NN; Zhang QY; Liu SQ; An QQ; Zhu XH; Liu Y; Yu CB; Li YF; Dong J; Li HC
    BMJ Open; 2022 Jul; 12(7):e059149. PubMed ID: 35902191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mortality during tuberculosis retreatment at a Ghanaian tertiary center: a retrospective cohort study.
    Bouton TC; Forson A; Kudzawu S; Zigah F; Jenkins H; Bamfo TD; Carter J; Jacobson K; Kwara A
    Pan Afr Med J; 2019; 33():111. PubMed ID: 31489089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-Resistant Tuberculosis in U.S.-Bound Immigrants and Refugees.
    Liu Y; Posey DL; Yang Q; Weinberg MS; Maloney SA; Lambert LA; Ortega LS; Marano N; Cetron MS; Phares CR
    Ann Am Thorac Soc; 2022 Jun; 19(6):943-951. PubMed ID: 34941475
    [No Abstract]   [Full Text] [Related]  

  • 19. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
    Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X
    Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.